Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients.
Clinical factors which might influence the absorption of subcutaneously injected 125I-NPH insulin were studied in 101 diabetics. The disappearance curve was monoexponential after a delay period of 1.5 +/- 0.8 h (mean +/- SD). Lipohypertrophy significantly prolonged insulin absorption (half life (T1/2) = 11.2 +/- 3.1 h, p = 0.0001). Low bicarbonate levels increased the absorption (T1/2 3.9 +/- 2.3 h, p less than 0.05). Lean diabetics had a faster absorption (6.2 +/- 1.9 h) than normal weight diabetics (7.5 +/- 2.0 h, p less than 0.02). Sex, age, diabetes duration and injection depth did not influence T1/2. The half life was significantly inversely correlated to the resting subcutaneous blood flow (r = 0.882, p less than 0.01). The overall interindividual coefficient of variation for insulin absorption in nonketotic diabetics was 27.4%. Also considerable intra-patient day-to-day variation was found (24.5%), and between different injection sites (30.2%). These variations emphasize the drawbacks of conventional insulin therapy in the management of insulin-requiring diabetics.
D000042:Absorption; D000328:Adult; D000367:Age Factors; D001835:Body Weight; D003920:Diabetes Mellitus / Q000378:metabolism*; D016883:Diabetic Ketoacidosis / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006801:Humans; D007279:Injections, Subcutaneous; D007336:Insulin, Isophane / Q000378:metabolism*; D007457:Iodine Radioisotopes / Q000378:metabolism*; D008297:Male; D012737:Sex Factors
D007457:Iodine Radioisotopes; D007336:Insulin, Isophane